publication venue for
- Should venetoclax be used with or without anti-CD20 therapy for CLL?. 19. 2021
- Highlights in B-cell malignancies from the 61st American Society of Hematology Annual Meeting: commentary.. 18 Suppl 8. 2020
- Management of relapsed/refractory follicular lymphoma.. 16 Suppl 10. 2018
- Frontline management of chronic lymphocytic leukemia.. 15 Suppl 10. 2017
- The use of CAR T cells in diffuse large B-cell lymphoma and mantle cell lymphoma.. 15. 2017
- Are chimeric antigen receptor T cells ready for prime time?. 14. 2016
- New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.. 13. 2015
- Integrating current treatment options for TKI-resistant chronic myeloid leukemia.. 12. 2014
- Highlights in B-cell malignancies from the 2013 American Society of Hematology annual meeting and exposition: commentary.. 12 Suppl 8. 2014
- Commentary.. 12. 2014
- Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.. 12 Suppl 5. 2014
- The role of tyrosine kinase inhibitors in hepatocellular carcinoma.. 12. 2014
- Unmet needs in the treatment of chronic lymphocytic leukemia: introduction.. 12 Suppl 3. 2014
- Clinical roundtable monograph: Emerging treatment options for TKI-resistant chronic myelogenous leukemia.. 10. 2012
- Antibody-drug conjugate technology development for hematologic disorders.. 10. 2012
- Is rituximab maintenance still standard of care in indolent non-hodgkin lymphoma?. 10. 2012
- The need for postoperative radiation therapy.. 10. 2012
- Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.. 9. 2011
- Tumor self-seeding in breast cancer.. 9. 2011
- Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.. 9. 2011
- Omacetaxine: the FDA decision.. 9. 2011
- Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.. 8. 2010
- Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.. 8. 2010
- New agents in early clinical trials for CLL therapy.. 8. 2010
- Clinical roundtable monograph. Current management and treatment of T-cell lymphoma: A multidisciplinary approach.. 8. 2010
- Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.. 8. 2010
- Pazopanib in renal cell carcinoma.. 8. 2010
- Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion.. 8. 2010
- Lessons learned from the development of kinase inhibitors.. 7. 2009
- The evolving role of axillary dissection.. 7. 2009
- Antibody treatment in lymphoma.. 7. 2009
- Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.. 7. 2009
- Utility of brain FDG-PET in primary CNS lymphoma.. 6. 2008
- New agents in hepatocellular carcinoma.. 6. 2008
- Is reduced-intensity conditioning the standard of care in the transplant setting?. 6. 2008
- Will radioimmunotherapy survive?. 5. 2007
- Advances at the Center for Cancer Research at the National Cancer Institute's Medical Oncology Branch.. 5. 2007
- Wall Street's perspective on oncology drug development.. 5. 2007
- The Development of rapamycin as an orphan drug.. 5. 2007
- Update on the use of imatinib mesylate.. 3. 2005
- Current treatment of myelofibrosis.. 3. 2005
- Current management of hormone-refractory prostate cancer.. 2. 2004
- Antibodies in the treatment of lymphoma.. 2. 2004
- Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.. 1. 2003
- The clinical importance of prognostic markers in CLL.. 20. 2022
- The future role of bispecific antibodies in lymphoma.. 20. 2022
- Looking ahead to new therapies in small cell lung cancer.. 16. 2018
- Patient-derived tumor xenograft models in drug development.. 15. 2017
- Treatment of multiple myeloma with carfilzomib in patients with renal injury.. 11. 2013
- New antibodies in the treatment of lymphoma.. 4. 2006
- Hodgkin's lymphoma in HIV: unusual presentations and improving outcomes. 2003
- Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary. 2017
- Highlights in T-cell lymphoma from the 2011 American Society of Hematology Annual Meeting and Exposition. 2012
- Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii. 2011
- A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings. 2007
- Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma? 2021
- Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. 2016
- New frontiers and treatment paradigms for thyroid carcinoma. 2014
- Clinical roundtable monograph: unmet needs in the treatment of chronic lymphocytic leukemia: integrating a targeted approach. 2014
- Sequential therapy in chronic myelogenous leukemia: where do emerging therapies fit within current treatment regimens? 2013
- Atypical hemolytic uremic syndrome (aHUS): making the diagnosis. 2012
- Diagnosis of atypical hemolytic uremic syndrome: a review of case studies. 2012
- Current treatment of peripheral T-cell lymphoma. 2011
- Clinical development of kinase inhibitors for the treatment of differentiated thyroid cancer. 2011
- Amphiphysin autoimmunity in paraneoplastic neurologic disease. 2009
- The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer. 2009
- Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma. 2008
- Prostate cancer vaccines: maximizing a suboptimal immune response for improved outcome. 2007
- New developments in the treatment of esophageal cancer. 2004
- CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia. 2016
- Pancreatic cancer: the role of molecular markers in diagnosis and management. 2011
- Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. 2009
- Combination treatment approaches and novel therapies for lymphoma. 2007
- Novel targets in solid tumors: MEK inhibitors. 2006
- The role of FDG-PET imaging in the management of lymphoma. 2004